Genetic Testing for Breast and Ovarian Cancer Mira Dx

The KRAS-variant is one of the first discovered members of a new class of genetic markers that predict increased cancer risk and unique treatment response to cancer therapy. The biology of the KRAS-variant affords great promise for both preventing and curing cancer in individuals with this inherited mutation. Variant is a strong biomarker of baseline immune status and inflammatory response. This has led us to apply the. Variant, as well as with other mutations in its class. Application of this class .

OVERVIEW

This web page miradx.com currently has a traffic ranking of zero (the smaller the superior). We have researched five pages inside the site miradx.com and found two websites referencing miradx.com. I found two contacts and addresses for miradx.com to help you connect with them. I found one social network accounts belong to this website. This web page miradx.com has been on the internet for seven hundred and eighty-six weeks, twenty-four days, ten hours, and two minutes.
Pages Analyzed
5
Links to this site
2
Contacts
2
Locations
2
Social Links
1
Online Since
Nov 2009

MIRADX.COM RANKINGS

This web page miradx.com has seen varying amounts of traffic all over the year.
Traffic for miradx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for miradx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for miradx.com

Date Range

All time
This Year
Last Year
Last Month

MIRADX.COM HISTORY

This web page miradx.com was created on November 18, 2009. It will go back on the market on November 18, 2019. As of today, it is seven hundred and eighty-six weeks, twenty-four days, ten hours, and two minutes old.
REGISTERED
November
2009
EXPIRED
November
2019

WEBPAGE AGE

15
YEARS
0
MONTHS
24
DAYS

LINKS TO BUSINESS

Genetic Cancer Research with Immediate Impact MiraKind is bringing important genetic discoveries to individuals who can benefit from them.

MiraKind is a Community of Education and Support for People and Families with the. An inherited genetic mutation associated with cancer. MiraKind conducts patient-centric studies to provide KRAS-variant individuals and their families access to groundbreaking genetic research and a community of support so that together, we can find actionable and meaningful strategies to prevent and treat cancer.

WHAT DOES MIRADX.COM LOOK LIKE?

Desktop Screenshot of miradx.com Mobile Screenshot of miradx.com Tablet Screenshot of miradx.com

CONTACTS

MiraDx, Inc.

martin verhoef

300 George Street

New Haven, Connecticut, 06511

UNITED STATES

MiraDx, Inc.

martin verhoef

300 George Street

New Haven, CT, 06511

UNITED STATES

MIRADX.COM HOST

Our web crawlers detected that the main page on miradx.com took three hundred and fifty-nine milliseconds to download. We could not find a SSL certificate, so in conclusion our crawlers consider this site not secure.
Load time
0.359 seconds
SSL
NOT SECURE
Internet Address
104.155.149.95

NAME SERVERS

ns13.domaincontrol.com
ns14.domaincontrol.com

BOOKMARK ICON

SERVER OPERATING SYSTEM AND ENCODING

I found that this website is implementing the nginx server.

TITLE

Genetic Testing for Breast and Ovarian Cancer Mira Dx

DESCRIPTION

The KRAS-variant is one of the first discovered members of a new class of genetic markers that predict increased cancer risk and unique treatment response to cancer therapy. The biology of the KRAS-variant affords great promise for both preventing and curing cancer in individuals with this inherited mutation. Variant is a strong biomarker of baseline immune status and inflammatory response. This has led us to apply the. Variant, as well as with other mutations in its class. Application of this class .

CONTENT

This web page miradx.com states the following, "The KRAS-variant is one of the first discovered members of a new class of genetic markers that predict increased cancer risk and unique treatment response to cancer therapy." Our analyzers saw that the website said " The biology of the KRAS-variant affords great promise for both preventing and curing cancer in individuals with this inherited mutation." The Website also said " Variant is a strong biomarker of baseline immune status and inflammatory response. This has led us to apply the. Variant, as well as with other mutations in its class. Application of this class ."

SIMILAR WEBSITES

Hermandad de la Soledad de Olivares Página web de la Hermandad de la Soledad de Olivares, Sevilla.

SALIDA DE NUESTRA SEÑORA DE LOS DOLORES DE OLIVARES 2018. Salida de Nuestra Señora de los Dolores de Olivares el Viernes Santo de 2018. LA VIRGEN DE LOS DOLORES ATAVIADA EN SU CAPILLA. La Virgen de los Dolores ya luce en su capilla ataviada después de la Semana Santa.